Maze Therapeutics MAZE Growth Metrics (2024-2026)

NASDAQ MAZE
$32.79 +0.34 (+1.05%)
As of: Oct 21, 2026 · 12:59 PM EDT
Reported Financials

Maze Therapeutics Quarterly Growth Metrics

Periods 9 quarters
Latest Jun 2026

Maze Therapeutics reported asset growth of 75.15% for the quarter ended Jun 2026. These growth metrics cover 9 quarters of results from Jun 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y) 65.10%26.10%75.15%
Assets (QoQ) 38.37%-8.81%39.05%-5.91%5.69%26.66%
Capital Expenditures Growth (1y)Capex Growth (1y) 7.17%145.62%-33.98%-94.38%-68.90%-72.77%
Capital Expenditures (QoQ)Capex (QoQ) -42.65%-35.62%487.38%-50.58%31.44%-82.70%-50.00%173.53%15.05%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 880.49%51.11%111.74%-3.84%-32.48%-23.40%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) 483.10%-14.54%31.55%49.57%-10.13%19.74%-40.26%5.03%1.95%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) -7.17%-145.62%-64,834.95%-16,988.76%2,198.66%-32,598.73%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ) 42.65%35.62%-487.38%50.58%-31.44%-16,918.58%-54.58%106.07%-2,147.90%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) -25.94%-120.72%-6.19%-23.51%-32.51%49.91%
Cash from Operations (QoQ)Cash from Ops. (QoQ) 718.88%-116.00%3.24%-31.46%-1.82%18.00%-12.53%-41.05%61.51%
EBITDA Margin (QoQ) -0.10M
EBIT Growth (1y) -26.37%-126.14%-36.06%-28.03%24.99%-31.70%
EBIT Margin (QoQ) -0.11M
EBIT (QoQ) 598.16%-117.36%-22.69%-19.09%-3.03%9.62%-15.45%30.23%-80.90%
EBT Growth (1y) -18.22%-123.92%-20.20%-15.79%26.16%-32.80%
EBT Margin (QoQ) -0.11M
EBT (QoQ) 607.63%-117.78%-19.27%-9.82%-2.72%10.67%-14.89%29.97%-84.76%
EPS (Basic) Growth (1y) 91.76%-113.23%93.59%65.74%60.78%1.41%
EPS (Basic) (QoQ) 141.79%-276.30%77.08%51.23%32.85%14.53%-22.39%44.16%-68.79%
EPS (Diluted) Growth (1y) 91.76%-123.90%93.59%60.96%60.78%1.41%
EPS (Diluted) (QoQ) 123.14%-418.37%79.89%44.42%32.85%14.53%-22.39%44.16%-68.79%
FCF Margin (QoQ) -0.10M
Free Cash Flow Growth (1y)FCF Growth (1y) -25.72%-121.01%-6.02%-20.41%-31.50%50.21%
Free Cash Flow (QoQ)FCF (QoQ) 710.93%-116.09%1.08%-29.31%-2.11%18.84%-12.36%-41.21%61.33%
Gross Profit Growth (1y) 1,633.95%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ) -68.27%
Net Cash Flow Growth (1y)NCF Growth (1y) 11,178.96%-120.57%305.17%-370.16%-90.24%113.00%
Net Cash Flow (QoQ)NCF (QoQ) 16,667.86%-117.55%285.42%106.68%-130.58%275.08%-344.15%107.46%-59.27%
Net Income Growth (1y) -0.90%-124.22%-21.55%-16.87%26.16%-32.80%
Net Income (QoQ) 527.94%-117.80%-19.50%-10.84%-2.72%10.67%-14.89%29.97%-84.76%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) -0.90%-342.57%-21.55%-514.43%26.16%-32.80%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) 142.73%-278.28%77.27%-482.76%-2.72%10.67%-14.89%29.97%-84.76%
Net Margin (QoQ) -0.10M
Operating Income Growth (1y)Op. Inc Growth (1y) -26.37%-126.14%-36.06%-28.03%24.99%-31.70%
Operating Income (QoQ)Op. Inc (QoQ) 598.16%-117.36%-22.69%-19.09%-3.03%9.62%-15.45%30.23%-80.90%
Operating Margin (QoQ) -0.11M
Profit After Tax Growth (1y)PAT Growth (1y) -18.22%-124.22%-21.66%-16.76%26.16%-32.80%
Profit After Tax (QoQ)PAT (QoQ) 601.41%-117.78%-19.72%-10.74%-2.72%10.67%-14.89%29.97%-84.76%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) -24.36%-25.85%-26.89%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) -5.31%-4.88%-7.79%-8.92%-7.18%-6.22%
Return on Assets [ROA] Growth (1y)ROA Growth (1y) 0.00M988.00
Return on Assets [ROA] (QoQ)ROA (QoQ) -0.01M319.00276.00201.00192.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) -0.01M0.00M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) -0.01M269.00258.00230.00246.00
Return on Equity [ROE] Growth (1y)ROE Growth (1y) 997.00
Return on Equity [ROE] (QoQ)ROE (QoQ) 427.00361.0053.00156.00
Return on Sales [ROS] Growth (1y)ROS Growth (1y) -0.51M-0.02M0.43M
Return on Sales [ROS] (QoQ)ROS (QoQ) -0.11M-0.51M-0.06M
Revenue (QoQ) -98.48%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) 39.65%51.12%64.92%199.64%120.37%183.81%
Share-based Compensation (QoQ)Stock Comp. (QoQ) -7.27%9.38%-360.14%152.93%0.34%19.37%57.17%17.06%29.23%
Total Debt (QoQ) 0.33%

Maze Therapeutics Growth Metrics API

Pull Maze Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MAZE&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY